79197-22-1

Upstream product

• 122037-30-3 (2R,3S,4S,5R,6R)-2-methyl-6-(2,2,2-trichloro-1-iminoethoxy)tetrahydro-2H-pyran-3,4,5-triyl tribenzoate 
• 122089-70-7 C₃₄H₂₈O₉ 
• 1146468-69-0 2,3,4-Tri-O-benzoyl-6-desoxy-α,β-D-galactopyranose 

Downstream Products

• 515-69-5 (-)-α-bisabolol 
• 1356133-36-2 O-3'-senecioyl α-bisabolol β-D-fucopyranoside 
• 1356133-38-4 O-3'-isovaleroyl α-bisabolol β-D-fucopyranoside 

Relevant academic research and scientific papers

Boronic acid-catalyzed final-stage site-selective acylation for the total syntheses of O-3′-acyl bisabolol β-D-fucopyranoside natural products and their analogues

The first concise total syntheses of O-3′-senecioyl α-bisabolol β-D-fucopyranoside (4a) and O-3′isovaleroyl α-bisabolol β-D-fucopyranoside (4b) were achieved through final-stage site-selective acylation via the activation of cis-vicinal diols by imidazole

α-bisabolol β-D-fucopyranoside as a potential modulator of β-amyloid peptide induced neurotoxicity: An in vitro & in silico study

Alzheimer's disease (AD) is a multifaceted neurodegenerative disorder affecting the elderly people. For the AD treatment, there is inefficiency in the existing medication, as these drugs reduce only the symptoms of the disease. Since multiple pathological